Dr. Roy Jensen sits down for a conversation with Dr. Joseph McGuirk, division director of The University of Kansas Cancer Center's Hematologic Malignancies and Cellular Therapeutics program. They discuss exciting advances in the research of chimeric antigen receptor (CAR) T-cell therapy, as well as Dr. McGuirk's journey to becoming a national leader in cellular therapy research and treatment. Dr. McGuirk also details a traumatic childhood experience, which inspired him to become a cancer researcher and doctor. In addition, Anne Holzbeierlein, an acute myeloid leukemia survivor who was treated at by Dr. McGuirk at KU Cancer Center, shares her story, as well as advice for others who may be facing a similar diagnosis.
If you appreciated this episode, please share, rate, subscribe and leave a review. For the latest updates, make you are following us on social media by searching for KU Cancer Center on Facebook, Instagram and Twitter.
Do you have questions about cancer? Would you like to participate in this podcast? We want to hear from you! Send us an email with your questions at benchtobedside@kumc.edu or leave us a voice message at (913) 588-3880. Your question may be featured on a future episode.
Links from this episode:
